401 filings
Page 10 of 21
8-K
sapbqnirsc
1 Nov 05
Oscient Pharmaceuticals to Present Clinical Data on FACTIVE® Tablets at CHEST 2005
12:00am
8-K
932p2rzt5dewp yi21x
19 Sep 05
Full Results Released from Phase III Trial Comparing Five-Day and Seven-Day Treatment
12:00am
POS AM
r9rv64qtmil6
2 Sep 05
Prospectus update (post-effective amendment)
12:00am
8-K
2yffsayybkz
3 Aug 05
Oscient Pharmaceuticals Reports Financial Results for Second Quarter of 2005
12:00am
8-K
ue69nv
20 Jul 05
Oscient Pharmaceuticals Announces Transition of Chairman of Board
12:00am
POS AM
n84l1fx
30 Jun 05
Prospectus update (post-effective amendment)
12:00am
UPLOAD
id4cz8001x0
13 Jun 05
Letter from SEC
12:00am
8-K
drnuwwdx
7 Jun 05
Other Events
12:00am
8-K
jbppg2jl84v8mkabm
6 Jun 05
Other Events
12:00am
POS AM
50a74g3hxgi3wvsuiu1
2 Jun 05
Prospectus update (post-effective amendment)
12:00am
ARS
s6ukkvl7iyz3s
6 May 05
Annual report to shareholders
12:00am
8-K
q4ud1 h5jwaet4lut4s
3 May 05
Oscient Pharmaceuticals Reports Financial Results for First Quarter
12:00am
8-K
woagpe0phr e6he
13 Apr 05
Entry into a Material Definitive Agreement
12:00am
8-K
ss1lkfgppy3xukm
6 Apr 05
Oscient Pharmaceuticals and LG Life Sciences Amend FACTIVE License Agreement
12:00am
8-K
bahig701aodwze
6 Apr 05
Oscient Pharmaceuticals Provides Preliminary Results for First Quarter
12:00am